Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMinoan Regulatory News (MIN)

Share Price Information for Minoan (MIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.675
Bid: 0.65
Ask: 0.70
Change: -0.075 (-10.00%)
Spread: 0.05 (7.692%)
Open: 0.75
High: 0.75
Low: 0.625
Prev. Close: 0.75
MIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results for the year ended 31 Oct 2020

30 Apr 2021 07:00

RNS Number : 1495X
Minoan Group PLC
30 April 2021
 

Preliminary Results Announcement

Minoan Group Plc (or "the Company" or "the Group") announces its Preliminary Results for the year ended 31 October 2020

Highlights

· Overall Group loss reduced by circa £1,201,000 to £876,000 (2020: £2,077,000).

· Finance costs reduced by £1,266,000

· Total equity at 31 October 2020 of £41,942,000 (2019: £42,257,000)

· Group has continued to progress the Crete project

· Refinanced its only secured indebtedness

· Reduced its overall cost base in Greece and the UK

· Appointed Deloitte to assist board and review plans

· Progressed with discussions re adjustments to its contract

· In a strong position to move towards commercialisation

 

Minoan Chairman, Christopher Egleton commented:

 

I am pleased that we have been able to make progress in what has been a very difficult period for any business associated with the tourism industry. The Crete project's inherent flexibility allows it to meet the changing demands in the post Covid world.

  

Minoan Group Plc's Preliminary Results Announcement for the year ended 31 October 2020 can be viewed on the Company's website, www.minoangroup.com, with effect from 30 April 2021.

 

 

For further information please visit www.minoangroup.com or contact:

Minoan Group Plc

 

Christopher Egleton

christopher.egleton@minoangroup.com

 

Bill Cole

william.cole@minoangroup.com

 

WH Ireland Limited

020 7220 1666

Adrian Hadden/Lydia Zychowska

 

Pello Capital Limited

020 7710 9610

Mark Treharne

 

Sapience Communications Limited

020 3195 3240

Richard Morgan Evans

 

 

 

Chairman's Statement

Introduction

 

The period under review, the year ended 31 October 2020, was dominated by the effects of the Covid pandemic. Nevertheless I am pleased to report that, as forecast, the loss for the year was substantially reduced.

During the year, the Group continued to progress the Crete project (the "Project") and refinanced its only secured indebtedness, whilst successfully reducing its overall cost base in Greece and the UK. Notwithstanding the pandemic, we have made steady progress and are well placed to progress the Project as we move into the post-pandemic environment, embracing the vacation environments most applicable to the post-pandemic world.

 

Financial Review

 

The reduction in the loss before taxation to £876,000 from £2,077,000 was largely due to the cancellation of warrants, which led to a credit rather than a charge for share based payments. This credit will not be repeated in the current year but neither will some of the other finance costs and, therefore, I expect that the costs going forward will remain at much lower levels than has been the case in recent years.

Operating costs rose to £864,000 from £799,000 wholly as a result of increases in legal and professional fees.

I am also pleased to report that discussions with our debt provider regarding a rearrangement of the existing terms have commenced.

 

The Project and Greece

 

Covid-19 has undoubtedly led to delays in the timetable we set ourselves in my Chairman's Statement last year. It has, however, been fortuitous in other ways. The true potential of the Project is being highlighted by the very changes in the market that have been driven by Covid-19, with the advantages of space, privacy and luxury already proving to be highly valued.

In order to ensure that the Company's business plan is robust we appointed Deloitte in Athens to conduct a review. This review, which involved all the key hotel financial and commercial assumptions as well as the legal and planning background alongside current and predicted conditions in the tourism market and the experience and expertise of the Group's team, is largely complete. I am pleased to be able to confirm that both Deloitte and we are satisfied that the current plan is both robust and practical in the current market.

As I reported last year, at the top end of the market the early indications of the effects of the Covid pandemic seemed to revolve around providing the space for enhanced social distancing. It now appears to have started to increase the attractiveness of "villas", partly because this style of accommodation and holiday allows guests a range of choices between complete privacy (isolation) whilst retaining the ability to be part of a wider hotel community.

The size, location, and topography of the Site allow for variations in design and therefore future product and mean that the Project is ideally suited to provide the flexibility necessary to meet changing market demands.

All of these factors have an impact on overall value, and shareholders will be pleased to know that, following discussions with its valuers, the Company is of the view that the value of the Project has not been impaired by the effects of the pandemic.

Further, as shareholders are aware from the updates already provided, discussions with The Public Welfare Ecclesiastical Foundation Panagia Akrotiriani regarding desirable adjustments to its contract and long lease are in progress.

Once these have been agreed we will accelerate commercial discussions with new and existing parties and bring them to conclusion.

Outlook

Whilst the pandemic has undoubtedly slowed progress over the last year, it has presented us with the opportunity to work on refining the master contract and highlighted the continuing value of the Project as the sector adapts to the changing needs of a post pandemic world. This puts us in a very strong position as we move towards commercialisation.

We have launched a new website in recent months, which I hope highlights to both shareholders and potential partners the scale of the opportunity in front of us. This can be found at www.minoangroup.com and we encourage investors to visit it. 

I am pleased to be able to say that I believe that I will be able to update shareholders on progress on all the major issues more frequently over the coming weeks and months.

 

Christopher W Egleton

Chairman

29 April 2021

 

 

 

 

 

Consolidated Statement of Profit and Loss and Other Comprehensive Income

Year ended 31 October 2020

 

 

2020

£'000

2019

£'000

Revenue

-

-

Cost of sales

-

-

Gross profit

-

-

 

 

 

Operating expenses

(864)

(799)

 

 

 

Other operating expenses:

 

 

Corporate development costs

-

-

Operating loss

(864)

(799)

 

 

 

Finance costs

(12)

(1,278)

 

 

 

Loss before taxation

(876)

(2,077)

 

 

 

Taxation

-

-

Loss after taxation

(876)

(2,077)

Other Comprehensive Income for the year

-

-

Total Comprehensive Income for the year

(876)

(2,077)

Loss for year attributable to equity holders of the Company

(876)

(2,077)

 

 

 

Loss per share attributable to equity holders of 

 

 

the Company: Basic and diluted

(0.20)p

(0.61)p

 

 

 

 

 

 

Consolidated Statement of Changes in Equity

Year ended 31 October 2020

 

Year ended 31 October 2020

 

Share capital

£'000

Share premium

£'000

Merger

reserve £'000

Warrant

Reserve

 £'000

Retained earnings £'000

Total

equity

£'000

Balance at 1 November 2019

17,188

36,119

9,349

3,094

(23,493)

42,257

Loss for the year

-

-

-

-

(876)

 (876)

 

Issue of ordinary shares at a premium

771

357

-

-

-

1,128

Share based payments reduction in Warrant reserve

-

-

-

(567)

-

(567)

 

 

 

 

 

 

 

 

Balance at 31 October 2020

17,959

36,476

9,349

2,527

(24,369)

41,942

 

Year ended 31 October 2019

 

Share capital

£'000

Share premium

£'000

Merger

reserve £'000

Warrant

Reserve

 £'000

Retained earnings £'000

Total

equity 

£'000

Balance at 1 November 2018

15,460

34,373

9,349

2,830

(21,416)

40,596

Loss for the year

-

-

-

-

(2,077)

 (2,077)

 

Issue of ordinary shares at a premium

1,728

1,746

-

-

-

3,474

Share based payments

-

-

-

-

-

-

Extension of warrant expiry date (see note 17)

-

-

-

264

-

264

 

Balance at 31 October 2019

17,188

36,119

9,349

3,094

(23,493)

42,257

 

 

 

Consolidated Statement of Financial Position as at 31 October 2020

 

 

2020£'000

2019£'000

Assets

 

 

Non-current assets

 

 

Intangible assets

3,583

3,583

Property, plant and equipment

157

157

Total non-current assets

3,740

3,740

Current assets

 

 

Inventories

46,431

45,848

Receivables

225

211

Cash and cash equivalents

6

24

Total current assets

46,662

46,083

 

 

 

Total assets

50,402

49,823

 

 

 

Equity

 

 

Share capital

17,959

17,188

Share premium account

36,476

36,119

Merger reserve account

9,349

9,349

Warrant reserve

2,527

3,094

Retained earnings

(24,369)

(23,493)

Total equity

41,942

42,257

 

 

 

Liabilities

 

 

Current liabilities

8,460

7,566

 

 

 

Total equity and liabilities

50,402

49,823

 

 

Consolidated Cash Flow Statement

Year ended 31 October 2020

 

 

Note to the Consolidated Cash Flow Statement

2020

£'000

2019

£'000

 

 

 

 

Cash flows from operating activities

 

 

 

Net cash (outflow) from continuing operations

1

(567)

(1,909)

Finance costs for continuing operations

 

(12)

(1,278)

Net cash generated from/(used) in operating activities

 

(579)

(3,187)

 

 

 

 

Cash flows from (investing) / divesting activities in discontinued operations

 

 

 

Purchase of property, plant and equipment

 

-

-

Net cash used in investing activities in discontinued operations

 

-

-

 

 

 

 

Cash flows from financing activities in continuing operations

 

 

 

Net proceeds from the issue of ordinary shares

 

1,128

3,738

Loans (repaid) / received

 

(567)

(547)

Net cash generated from financing activities in continuing operations

 

561

3,191

Net increase/(decrease) in cash

 

(18)

4

Cash transferred to non-current assets held for sale

 

-

-

 

 

(18)

4

Cash at beginning of year

 

24

20

Cash at end of year

 

6

24

 

 

 

Note to the Consolidated Cash Flow Statement

Year ended 31 October 2020

 

1 Cash flows from operating activities in continuing operations

 

 

2020

£'000

2019

£'000

Loss before taxation

(876)

(2,077)

Finance costs

12

1,278

Depreciation

-

-

Exchange gain relevant to property, plant and equipment

-

4

Increase in inventories

(583)

(467)

(Decrease)/Increase in receivables

(14)

4

Increase/(Decrease) in current liabilities

894

(651)

Net cash (outflow) from continuing operations

(567)

(1,909)

 

Notes to the Financial Statements

Year ended 31 October 2020

 

1 General information

The financial information set out in this announcement does not constitute statutory financial statements for the year ended 31 October 2020 or 31 October 2019. The report of the auditors on the statutory financial statements for the year ended 31 October 2020 and 31 October 2019 was not qualified.

The report of the auditor on the statutory financial statements for each of the years ended 31 October 2020 and 31 October 2019 did not contain statements under section 498(2) or (3) of the Companies Act 2006. The statutory financial statements for the year ended 31 October 2019 have been delivered to the Registrar of Companies. The financial statements for the year ended 31 October 2020 will be delivered to the Registrar of Companies following the Company's Annual General Meeting.

 

The Company is a public limited company incorporated in England and Wales. The Company's principal activity in the year under review was that of a holding and management company of a Group involved in the design, creation, development and management of environmentally friendly luxury hotels and resorts plus the provision of general management services.

 

2 Accounting policies

 

Basis of preparation

The financial statements are prepared under the historical cost convention except for where financial instruments are stated at fair value.

Adoption of new and revised Standards

The International Accounting Standards Board and IFRIC have issued the following new and revised standards and interpretations with an effective date after the date of these financial statements, which have been endorsed and issued by the EU: 

 

Standard

 

Details of amendment

 

 Effective

date

 

IFRS 3 Business Combinations Amendments updating a reference to 1 January 2022

the Conceptual Framework

 

 

IAS 1 Presentation of Financial Amendments regarding the classification of 1 January 2023

Statements liabilities

Amendments regarding the disclosure of 1 January 2023

accounting policies

IAS 8 Accounting Policies, Amendments regarding the definition of 1 January 2023

Changes in Accounting accounting estimates

Estimates and Errors

 

IAS 16 Property, Plant and Amendments prohibiting a company from 1 January 2022

Equipment deducting from the cost of property, plant and

equipment amounts received from selling items

produced while the company is preparing the asset

for its intended use

 

IAS 37 Provisions, Contingent Amendments regarding the costs to include 1 January 2022

Liabilities and when assessing whether a contract is onerous

Contingent Assets

 

 

Going concern

The directors have considered the financial and commercial position of the Group in relation to its project in Crete (the "Project"). In particular, the directors have reviewed the matters referred to below.

Following the unanimous approval of a Plenum of the Greek Council of State, the highest court in Greece, the Presidential Decree granting land use approval for the Project was issued on 11 March 2016 and was published in the Government Gazette. The planning rules for the Project are now enshrined in law. The appeals lodged against the Presidential Decree have been rejected by the Greek Supreme Court.

Accordingly, the directors consider that they will conclude further Project joint venture agreements in the near term. In addition, the directors are considering other options which would have a major beneficial impact on the Group's resources.

In addition to specific Project related matters as noted above, and as has been the case in the past, the Group continues to need to raise capital in order to meet its existing finance and working capital requirements. While the directors consider that any necessary funds will be raised as required, the ability of the Company to raise these funds is, by its nature, uncertain.

Having taken these matters into account, the directors consider that the going concern basis of preparation of the financial statements is appropriate.

 

Basis of consolidation

The consolidated financial statements incorporate the financial statements of the Company and all its subsidiaries as at 31 October 2020 using uniform accounting policies. The Group's policy is to consolidate the result of subsidiaries acquired in the year from the date of acquisition to the Group's next accounting reference date. Intra-group balances are eliminated on consolidation.

Acquisitions of subsidiaries and businesses are accounted for using the acquisition method. The consideration for each acquisition is measured at the aggregate of the fair values of the assets given, liabilities incurred and equity instruments issued by the Group in exchange for control of the acquired business. Acquisition related costs are recognised in the consolidated statement of comprehensive income as incurred.

Critical accounting estimates and judgements

The preparation of the financial statements in accordance with generally accepted financial accounting principles requires the directors to make critical accounting estimates and judgements that affect the amounts reported in the financial statements and accompanying notes. The estimates and assumptions that have a significant risk of causing material adjustments to the carrying value of assets and liabilities within the next financial year are discussed below:

in capitalising the costs directly attributable to the Project (see inventories below), and continuing to recognise goodwill relating to the Project, the directors are of the opinion that the Project will be brought to fruition and that the carrying value of inventories and goodwill is recoverable; and as set out above, the directors have exercised judgement in concluding that the company and group is a going concern.

Goodwill

Goodwill arising on acquisitions represents the difference between the fair value of the net assets acquired and the consideration paid and is recognised as an asset.

Goodwill arising on acquisition is allocated to cash-generating units. The recoverable amount of the cash-generating unit to which goodwill has been allocated is tested for impairment annually, or on such other occasions that events or changes in circumstances indicate that it might be impaired. Any impairment is recognised immediately as an expense and is not subsequently reversed.

 

Property, plant and equipment

Property, plant and equipment is stated at historical cost less accumulated depreciation and any recognised impairment loss.

Depreciation is provided in order to write off the cost of each asset, less its estimated residual value, over its estimated useful life on a straight line basis as follows:

Plant and equipment:

3 to 5 years

Fixtures and fittings:

3 years

 

 

Where the carrying amount of an asset is greater than its estimated recoverable amount, it is written down immediately to its recoverable amount.

Investments

Investments in subsidiaries are stated at cost less any impairment deemed necessary.

Inventories 

Inventories represent the actual costs of goods and services directly attributable to the acquisition and development of the Project and are stated at the lower of cost and net realisable value.

 

Foreign currency

A foreign currency transaction is recorded, on initial recognition in Euros, by applying to the foreign currency amount the spot exchange rate between the functional currency and the foreign currency at the date of the transaction.

At the end of the reporting period:

- foreign currency monetary items are translated using the closing rate;

- non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rate at the date of the transaction; and

- non-monetary items that are measured at fair value in a foreign currency are translated using the exchange rates at the date when the fair value was determined.

Exchange differences arising on the settlement of monetary items or on translating monetary items at rates different from those at which they were translated on initial recognition during the period or in previous annual financial statements are recognised in profit or loss in the period in which they arise.

When a gain or loss on a non-monetary item is recognised to other comprehensive income and accumulated in equity, any exchange component of that gain or loss is recognised to other comprehensive income and accumulated in equity. When a gain or loss on a non-monetary item is recognised in profit or loss, any exchange component of that gain or loss is recognised in profit or loss.

Cash flows arising from transactions in a foreign currency are recorded in Euros by applying to the foreign currency amount the exchange rate between the Euros and the foreign currency at the date of the cash flow.

Cash and cash equivalents

Cash and cash equivalents include cash in hand and short-term deposits, with a maturity of less than three months, held with banks.

Trade and other receivables

Trade and other receivables are recognised initially at fair value and shown less any provision for amounts considered irrecoverable. They are subsequently measured at an amortised cost using the effective interest rate method, less irrecoverable provision for receivables.

Trade and other payables

Trade and other payables are recognised initially at fair value and subsequently measured at amortised cost using the effective interest rate method.

Loans

Loan borrowings are recognised initially at fair value net of transaction costs incurred. Borrowings are subsequently stated at amortised cost and any difference between the proceeds (net of transaction costs) and the redemption value is recognised as a borrowing cost over the period of the borrowings using the effective interest method

Share-based payments

The Group has a Long Term Incentive Plan ("LTIP") in which any director or employee selected by the remuneration committee may participate. Awards under the LTIP have been granted on the basis that certain performance conditions will be met.

The Company has also granted options and warrants to purchase Ordinary Shares. The fair values of the LTIP awards, options and warrants are calculated using the Black-Scholes and Binomial option pricing models as appropriate at the grant date. The fair value of LTIP awards and options are charged to profit or loss over their vesting periods, with a corresponding entry recognised in equity. This charge does not involve any cash payment by the Group.

Where warrants are issued in conjunction with a loan instrument, the fair value of the warrants forms part of the total finance cost associated with that instrument and is released to profit or loss through finance costs over the term of that instrument using the effective interest method.

Taxation 

Current taxes, where applicable, are based on the results shown in the financial statements and are calculated according to local tax rules using tax rates enacted, or substantially enacted, by the statement of financial position date and taking into account deferred taxation. Deferred tax is computed using the liability method. Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities and are measured using enacted rates and laws that will be in effect when the differences are expected to reverse. Deferred tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction that at the time of the transaction affects neither accounting, nor taxable profit or loss. Deferred tax assets are recognised to the extent that it is probable that future taxable profits will arise against which the temporary differences will be utilised.

Deferred tax is provided on temporary differences arising on investments in subsidiaries except where the timing of the reversal of the temporary difference is controlled by the Group and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax assets and liabilities arising in the same tax jurisdiction are offset.

The Group is entitled to a tax deduction for amounts treated as compensation on exercise of certain employee share options. As explained under "Share-based payments" above, a compensation expense is recorded in the Group's statement of comprehensive income over the period from the grant date to the vesting date of the relevant options. As there is a temporary difference between the accounting and tax bases a deferred tax asset is recorded. The deferred tax asset arising is calculated by comparing the estimated amount of tax deduction to be obtained in the future (based on the Company's share price at the statement of financial position date) with the cumulative amount of the compensation expense recorded in the statement of comprehensive income. If the amount of estimated future tax deduction exceeds the cumulative amount of the remuneration expense at the statutory rate, the excess is recorded directly in equity against retained earnings.

3 Information regarding directors and employees

 

Directors' and key management remuneration

 

Costs taken toinventories

Costs taken toprofit or loss

Total

 

£'000

£'000

£'000

Year ended 31 October 2020

 

 

 

Fees

35

144

179

Sums charged by third parties fordirectors' and key management services

134

70

204

Share-based payments (note 17)

-

-

-

 

169

214

383

 

 

 

 

Year ended 31 October 2019

 

 

 

Fees

(85)

274

189

Sums charged by third parties fordirectors' and key management services

111

70

181

Share-based payments (note 17)

-

-

 

 

26

344

370

 

The total directors' and key management remuneration shown above includes the following amounts in respect of the directors of the Company.

 

 

2020

2019

 

Fees/Sums charged by third parties

Share-based payments

Fees/Sums charged by third parties

Share-based payments

 

£'000

£'000

£'000

£'000

C W Egleton (Chairman)

134

-

162

-

B D Bartman

35

-

35

-

G D Cook

35

-

35

-

T R C Hill

35

-

48

-

 

239

-

280

-

 

 

Staff costs during the period (including directors and key management)

 

 

Costs taken to inventories

Costs taken toprofit or loss

Total

 

£'000

£'000

£'000

Year ended 31 October 2020

 

 

 

Salaries and fees

35

145

180

Social security cost

6

13

19

 

41

158

199

 

 

 

 

Year ended 31 October 2019

 

 

 

Salaries and fees

-

250

250

Social security cost

-

30

30

 

-

280

280

 

Note: Staff costs exclude sums charged by third parties for directors' services.

 

2020

2019

 

No.

No.

Group monthly average number of persons employed

 

 

Directors

7

7

Management, administration and sales

-

2

 

 

4 Loss before taxation

 

The loss before taxation is stated after charging:

 

 

2020

£'000

2019

£'000

Auditor's remuneration:

 

 

Group audit fees

20

21

 

 

5 Segmental information

 

The Group strategy and growth objectives necessitate the building of an associated infrastructure. The Group considers it appropriate to identify separately the corporate development division together with costs related to acquisitions. Accordingly, the Group is organised into two divisions both by business segment and geographical location:

· the luxury resorts division, currently being the development of a luxury resort in Crete, which includes the central administration costs of the Group and which is a continuing operation;

 

· the corporate development division (UK) as described above, which is a continuing operation.

 

The information presented below is consistent with how information is presented to the Board, with the Group's accounting policies and with the geographical location of the relevant divisions.

 

 

2020

 

Luxury Resorts

Corporate Development

Total

 

£'000

£'000

£'000

Operating expenses

(864)

-

(864)

 

(864)

-

(864)

Charge in respect of share-based payments

-

-

-

Charge related to assets held for sale

-

-

-

Operating (loss)/profit

(864)

-

(864)

Finance costs

(12)

-

(12)

(Loss)/profit before taxation

(876)

-

(876)

Taxation

-

-

-

(Loss)/profit after taxation

(876)

-

(876)

 

 

 

 

Operating expenses include:

 

 

 

Depreciation and amortisation

-

-

-

 

 

 

 

Assets/liabilities

 

 

 

Goodwill

3,583

-

3,583

Other non-current assets

157

-

157

Current assets

46,662

-

46,662

Total assets

50,402

-

50,402

 

 

 

 

Total and current liabilities

8,460

-

8,460

 

 

 

2019

 

Luxury Resorts

Corporate Development

Total

 

£'000

£'000

£'000

Operating expenses

(799)

-

(799)

 

(799)

-

(799)

Charge in respect of share-based payments

-

-

-

Charge related to assets held for sale

-

-

-

Operating (loss)/profit

(799)

-

(799)

Finance costs

(1,278)

-

(1,278)

(Loss)/profit before taxation

(2,077)

-

(2,077)

(Loss)/profit after taxation

(2,077)

-

(2,077)

 

 

 

 

Operating expenses include:

 

 

 

Depreciation and amortisation

-

-

-

 

 

 

 

Assets/liabilities

 

 

 

Goodwill

3,583

-

3,583

Other non-current assets

157

-

157

Current assets

46,083

-

46,083

Total assets

49,823

-

49,823

 

 

 

 

Total and current liabilities

7,566

-

7,566

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR DDGDSXBDDGBC
Date   Source Headline
30th Apr 202411:55 amRNSResult of Annual General Meeting
30th Apr 20247:00 amRNSUpdate
29th Apr 20244:40 pmRNSIssue of Shares
8th Apr 20247:00 amRNSNotice of Annual General Meeting
8th Mar 20247:00 amRNSChange of Director
5th Jan 20247:00 amRNSOption Expiry Extension and Shareholder Update
14th Nov 20237:00 amRNSIssue of Shares
10th Nov 202311:46 amRNSResults of AGM and GM
10th Nov 20237:00 amRNSShareholder Update
18th Oct 20237:00 amRNSNotices for the Re-convened AGM & General Meeting
29th Sep 20237:00 amRNSTiming of Forthcoming Meetings
29th Aug 20237:00 amRNSLoan Repayment & Extension and Share Issuance
1st Aug 20237:05 amRNSIssue of Shares
1st Aug 20237:00 amRNSInitial Agreement with Hotel Operator
31st Jul 20237:00 amRNSInterim Results Announcement
5th Jun 20237:00 amRNSMinoan Group Publishes Research Note
28th Apr 202310:58 amRNSResult of Annual General Meeting
28th Apr 20237:04 amRNSAnnual Results for the Year Ended 31 October 2022
6th Apr 20237:00 amRNSNotice of Annual General Meeting
21st Mar 20239:47 amRNSExercise of Options
5th Jan 20237:00 amRNSUpdate and Option Expiry Dates
9th Dec 20227:00 amRNSAppointment of Savills as an Advisor
24th Oct 20222:15 pmRNSPlacing and Directors’ Shareholdings
13th Oct 20227:00 amRNSAppointment to the Board of Loyalward Limited
29th Jul 20221:55 pmRNSInterim Results Announcement
26th Jul 20227:00 amRNSSignificant Shareholding
20th Jul 20227:00 amRNSShare Issue
18th Jul 20227:00 amRNSLoan Extension
29th Jun 20222:09 pmRNSCompany Update
6th Jun 20223:35 pmRNSResult of Re-convened Annual General Meeting
12th May 20227:00 amRNSNotice of Re-convened Annual General Meeting
3rd May 20224:49 pmRNSPlacing and Director / PDMR Shareholding
29th Apr 202210:32 amRNSResult of Annual General Meeting
28th Apr 20227:00 amRNSPreliminary Results for the Year Ended 31 Oct 2021
7th Apr 20227:00 amRNSNotice of Annual General Meeting
25th Mar 202211:25 amRNSGeorge Mergos Appointed Chair of Loyalward Limited
15th Feb 20227:00 amRNSCompany Update
30th Dec 20217:00 amRNSShare Issue and Option Expiry Dates
9th Dec 20217:00 amRNSUpdate on new Law on Strategic Investments
1st Dec 202112:45 pmRNSNew Development Law and Loan Extension
29th Oct 202111:27 amRNSLoan Extension
30th Jul 20217:00 amRNSResults of Placing
29th Jul 20217:00 amRNSInterim Results for the period ended 30 April 2021
28th May 202110:43 amRNSResult of Re-convened AGM
6th May 20217:00 amRNSNotice of Re-convened Annual General Meeting
30th Apr 202110:25 amRNSResult of AGM
30th Apr 20217:00 amRNSPreliminary Results for the year ended 31 Oct 2020
14th Apr 202112:54 pmRNSHolding(s) in Company
14th Apr 202112:48 pmRNSSignificant Shareholding
8th Apr 20217:00 amRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.